Related Experiment Video
Updated: Aug 28, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience
Susan dosReis1,2, Laura M Bozzi3,4, Beverly Butler4,5
1Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, 21201, USA. sdosreis@rx.umaryland.edu.
Major depressive disorder (MDD) patients prioritize treatment mode, speed, outcomes, and cost. Understanding these preferences can improve depression care by incorporating patient values.
Area of Science:
- Psychiatry and Mental Health
- Health Services Research
- Patient-Reported Outcomes
Background:
- Major depressive disorder (MDD) significantly impacts individuals' lives, necessitating treatments aligned with patient priorities.
- Current treatment selection may not fully capture patient preferences regarding efficacy, duration, and cost.
- Understanding patient trade-offs is crucial for developing patient-centered depression care strategies.
Purpose of the Study:
- To identify key treatment attributes and desired outcomes for individuals with major depressive disorder (MDD).
- To develop and pre-test a stated preference instrument, specifically a discrete choice experiment (DCE), for assessing MDD treatment preferences.
- To inform the design of more effective and patient-aligned depression management strategies.
Main Methods:
- A three-phase survey study involving 20 adults with MDD to design and pre-test a discrete choice experiment (DCE) instrument.
- Engagement with patient advocates and a multi-disciplinary advisory group to refine DCE attributes.
- Pre-testing the DCE instrument with ten adults diagnosed with MDD.
Main Results:
- Six initial attributes were identified: treatment mode, time to effect, hopefulness, productivity impact, social relations, and out-of-pocket costs.
- Refinements were made to treatment mode (medicine, medicine + psychotherapy, all modalities), time to effect (4, 6, 9 weeks), and monthly costs ($30, $90, $270).
- MDD treatment preferences indicated significant trade-offs between treatment modality, speed of effect, functional outcomes, and cost.
Conclusions:
- Patient preferences for major depressive disorder (MDD) treatments involve complex trade-offs.
- Incorporating patient-reported preferences into decision-making tools can enhance the relevance and effectiveness of depression treatments.
- This research highlights the value of patient-centered approaches in mental health care.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Cognitive Therapy

